Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2021

Jul 2, 2021

29841_dirs_2021-07-01_7f2bfd08-7917-4ff7-bf17-22882f643391.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-06-30

Reporting Person: Kirk Jennifer M (Chief Accounting Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 7104 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Performance Share Units $ Performance Share Units (3373) Direct
Stock Option (Right to Buy) $111.18 2031-02-01 Ordinary Shares (11123) Direct

Footnotes

F1: Vests on August 3, 2023.

F2: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,373 shares will be issued. The actual number of shares to be issued could range from a low of 675 at minimum performance to a high of 6,746 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.